Harrow Health (HROW) Financials

$32.74

$-0.39 (-1.18%)

As on 18-Sep-2026 10:37EDT

Market cap

$1,293 Mln

Revenue (TTM)

$276 Mln

P/E Ratio

--

P/B Ratio

85.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	275.59	272.30	199.61	130.19	88.60	72.48
Cost of Revenue	73.64	67.93	49.25	39.64	25.38	18.21
Gross Profit	201.96	204.37	150.37	90.55	63.21	54.26
Operating Expenses	196.26	165.76	141.55	90.12	61.29	52.65
Operating Profit (EBIT)	5.70	38.61	8.82	0.43	1.92	1.61
Other Income	--	--	--	--	-8.69	-14.05
Profit before Tax	-33.43	-1.72	-17.32	-23.71	-14.01	-17.87
Provision for Tax	3.80	3.42	0.16	0.70	0.08	0.13
Profit after Tax (Net Income)	-37.23	-5.14	-17.48	-24.41	-14.09	-18.01
Minority Interest	--	--	--	--	--	0.01
Consolidated Profit	--	--	--	--	-14.09	-18.48

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	15.20	52.45	69.65	70.36	26.89	11.29
Minority Interest	--	--	--	--	-0.36	-0.36
Non-Current Liabilities	299.80	251.09	228.33	192.41	111.51	77.68
Current Liabilities	102.17	96.30	91.34	49.34	18.63	9.72
Total Liabilities	518.99	399.48	388.97	311.76	157.02	98.33

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	187.51	187.73	199.32	172.68	37.17	37.67
Current Assets	229.31	211.75	189.65	139.07	118.26	60.66
Total Assets	518.99	399.48	388.97	311.76	157.02	98.33
Total Debt*	300.74	251.98	228.83	190.50	104.90	77.96
Net Current Assets	127.14	115.45	98.31	90.14	99.63	50.94

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	43.86	-22.20	3.84	1.71	5.08
Cash Flow from Investing Activities	--	-5.46	-33.16	-152.55	-1.74	-18.69
Cash from Financing Activities	--	-12.72	28.53	126.53	54.14	51.47
Net Cash Inflow / Outflow	--	--	--	--	54.10	37.87

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.00	-0.14	-0.49	-0.69	-0.48	-0.66
Cash EPS ($)	--	0.40	-0.08	-0.34	-0.35	-0.57
Adjusted Book Value ($)	--	1.43	1.95	1.99	0.91	0.41
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	1.19	-0.62	0.11	0.06	0.18
Free Cash Flow per Share ($)	--	1.16	-1.70	-4.21	-0.21	-0.85

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-1.70	-6.25	-12.43	-12.75	-25.73
ROE (%)	-110.06	-8.42	-24.97	-50.21	-73.80	-93.62
ROA (%)	-6.69	-1.30	-4.99	-10.41	-11.03	-23.12
EBIT Margin (%)	0.20	8.25	4.55	0.62	-7.64	4.64
Net Margin (%)	-13.51	-1.89	-8.76	-18.75	-17.63	-30.82
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	21.05	0.36	0.53	0.47	0.22	0.48
EBIT Growth (%)	-96.17	147.45	1,018.99	111.98	-301.22	349.60
Net Profit Growth (%)	-263.96	70.60	28.39	-73.30	21.77	-436.40
EPS Growth (%)	-236.15	0.71	0.29	-0.44	0.27	-4.03
Book Value Growth (%)	-68.16	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-350.51	-68.72	-16.22	-30.83	-13.18
Price / Book Value	85.06	34.35	17.25	5.63	16.16	21.03
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	132.68	47.88	62.35	42.16	-111.12	51.85
Close Price ($)	42.47	49.00	33.55	11.20	14.76	8.64
High Price ($)	54.85	51.53	59.23	28.25	15.14	12.99
Low Price ($)	28.54	20.85	9.13	7.60	5.40	6.00
Market Cap ($ Cr)	1,292.58	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	19.24	4.80	3.29	2.71	3.90	6.91
Short term debt to equity ratio	0.06	0.02	0.01	0.01	0.03	0.02
Current Ratio	2.24	2.20	2.08	2.82	6.35	6.24
Quick Ratio	2.08	2.06	1.96	2.60	6.00	5.81
Interest Coverage	-0.45	0.93	0.40	0.04	-0.93	0.62

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	43.02	40.72	58.41	28.03	7.21	6.23
Asset Turnover	0.50	0.69	0.57	0.56	0.69	0.93
Receivable days	--	152.57	140.06	60.14	22.48	18.09
Inventory Days	--	65.12	79.99	80.20	77.40	82.01
Payable days	--	199.25	223.20	184.54	171.28	88.42
Cash Conversion Cycle	--	18.45	-3.15	-44.20	-71.40	11.68

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.